Creative Planning’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Sell
44,794
-778
-2% -$2.2K ﹤0.01% 3983
2026
Q1
$110K Buy
45,572
+1,764
+4% +$4.81K ﹤0.01% 3880
2025
Q4
$191K Sell
43,808
-2,300
-5% -$12.4K ﹤0.01% 3571
2025
Q3
$194K Buy
46,108
+2,084
+5% +$7.4K ﹤0.01% 3505
2025
Q2
$126K Buy
44,024
+1,843
+4% +$4.87K ﹤0.01% 3379
2025
Q1
$114K Sell
42,181
-844
-2% -$3.17K ﹤0.01% 3222
2024
Q4
$102K Buy
+43,025
New +$114K ﹤0.01% 3154

Other funds holding GNLX

Creative Planning's GNLX Position: Q2 2026 in Review

Creative Planning reduced its Genelux (GNLX) stake by 1.7% in Q2 2026, selling an estimated $2.2K and leaving 44,794 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3983.

Creative Planning first reported a position in GNLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $194K in Q3 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Creative Planning held 44,794 shares of Genelux worth $135K as of Q2 2026.
  • Creative Planning sold 778 Genelux shares in Q2 2026, an estimated $2.2K.
  • Genelux made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3983 holding.
  • Creative Planning first reported a position in Genelux in Q4 2024 and has held it in 7 quarters since.
  • Creative Planning's Genelux position peaked at $194K in Q3 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.